131052-43-2 Usage
Uses
Used in Pharmaceutical Research and Drug Development:
1-(3-FURYL)METHANAMINE HYDROCHLORIDE is used as a building block for the synthesis of various compounds with potential biological activities. Its unique structure allows for the creation of new molecules that can target specific biological pathways or receptors, contributing to the discovery of novel therapeutic agents.
Used in Organic Synthesis:
1-(3-FURYL)METHANAMINE HYDROCHLORIDE is used as a reagent in organic synthesis, facilitating the formation of complex organic molecules. Its presence in reactions can lead to the production of a wide range of chemical products, expanding the scope of organic chemistry.
Used in the Production of Functionalized Amines and Heterocycles:
1-(3-FURYL)METHANAMINE HYDROCHLORIDE serves as a precursor for the production of other functionalized amines and heterocycles. These compounds are essential in various chemical and pharmaceutical applications, including the development of new drugs and the synthesis of advanced materials.
Used in Therapeutic Applications:
Due to its unique chemical structure and potential medicinal properties, 1-(3-FURYL)METHANAMINE HYDROCHLORIDE has the potential to be used in various therapeutic applications. Its ability to interact with biological systems may lead to the development of new treatments for a range of diseases and conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 131052-43-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,1,0,5 and 2 respectively; the second part has 2 digits, 4 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 131052-43:
(8*1)+(7*3)+(6*1)+(5*0)+(4*5)+(3*2)+(2*4)+(1*3)=72
72 % 10 = 2
So 131052-43-2 is a valid CAS Registry Number.
InChI:InChI=1/C5H7NO.ClH/c6-3-5-1-2-7-4-5;/h1-2,4H,3,6H2;1H
131052-43-2Relevant articles and documents
Quinazoline derivatives possessing anti-tumor activity
-
, (2008/06/13)
The invention relates to quinazoline derivatives, or pharmaceutically-acceptable salts thereof, which possess anti-tumor activity; to processes for their manufacture; and to pharmaceutical compositions containing them. The invention provides a quinazoline of the formula: STR1 wherein R1 is hydrogen or amino, or alkyl or alkoxy each of up to 6 carbon atoms; or R1 is substituted alkyl or alkoxy each of up to 3 carbon atoms; R2 is hydrogen, alkyl, alkenyl, alkynyl, hydroxyalkyl, halogenoalkyl or cyanoalkyl each of up to 6 carbon atoms; Ar is phenylene or heterocyclene; L is a group of the formula --CO.NH--, --NH.CO--, --CO.NR3 --, --NR3. CO--, --CH=CH--, --CH2 O--, --OCH2, --CH2 S--, --SCH2 --, --CO.CH2 --, --CH2.CO-- or --CO.O--, wherein R3 is alkyl of up to 6 carbon atoms; and Y is aryl or heteroaryl or a hydrogenated derivative thereof: or Y is a group of the formula --A--Y1 in which A is alkylene, cycloalkylene, alkenylene or alkynylene each of up to 6 carbon atoms and Y1 is aryl or heteroaryl or a hydrogenated derivative thereof; or a pharmaceutically-acceptable salt thereof.